This article explores Leash Bio, a startup focused on machine learning for drug discovery. It highlights the challenges of ensuring model accuracy and the potential for unintentional bias in research, while showcasing Leash Bio's commitment to ethical practices in a complex field.

Machine Learning and Design Thinking share a fundamental philosophy of iterative improvement through feedback loops. By comparing concepts like backpropagation in machine learning to design thinking processes, the article highlights how both disciplines learn from errors and refine their approaches for better outcomes. The emphasis is on continuous learning and small adjustments leading to innovation.

Understanding and monitoring bias in machine learning models is crucial for ensuring fairness and compliance, especially as AI systems become more autonomous. The article discusses methods for identifying bias in both data and models, highlighting the importance of analyzing demographic information during training and deployment to avoid legal and ethical issues. It also introduces metrics and frameworks, such as those in AWS SageMaker, to facilitate this analysis and ensure equitable outcomes across different demographic groups.